The forest and the trees: the human costs of cancer.
Explore the source record for details and available documents.
Aged↗
Biomedical subjects
Larry G Kessler
Publications and source records attributed to Larry G Kessler.
The US Food and Drug Administration perspective on cancer biomarker development.
Despite the intense interest in biomarker development for cancer management, few biomarker assays for diagnostic uses have been submitted to the US Food and Drug Administration (FDA). What challenges must researchers overcome to bring cancer-detection technologies to the market and, therefore, into clinical use?
Biological Assay↗
Part II: Sealing holes in the safety net.
Explore the source record for details and available documents.
Brachytherapy↗
Much ado about mammography variability.
Explore the source record for details and available documents.
False Positive Reactions↗
Does economics matter when treating advanced non-small cell lung cancer?
Explore the source record for details and available documents.
Antineoplastic Combined Chemotherapy Protocols↗